This approval enhances Alembic Pharma’s portfolio, which now totals 216 ANDAs from the USFDA, including 188 final and 28 ...

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the ...

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

GlaxoSmithKline is under pressure from shareholders to rein in pay for its incoming chief executive, Emma Walmsley, according to reports. Walmsley is set to take over from Sir Andrew Witty when he ...

Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Meningococcal VaccinesGlobal Strategic Business Report to 2030 Featuring Baxter International, Bio-Med, GlaxoSmithKline, Pfizer, Sanofi, and Serum Institute of India Among Others GlobeNewswire (Press ...